Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT): An Open-Label, Multicentre, Randomised, Controlled Trial
Mohammed Bosaeed, Ebrahim Mahmoud, Ahmad M. Alharbi, Hadeel Altayeib et autres
5 citations
SSRN Electronic Journal